Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Coherus Bio (NQ: CHRS ) 1.040 -0.010 (-0.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Coherus Bio < Previous 1 2 3 4 5 6 7 Next > CHRS Stock Earnings: Coherus BioSciences Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 CHRS stock results show that Coherus BioSciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary June 30, 2024 Shanghai Henlius Biotech agreed to be a wholly owned subsidiary of Fosun in a $690 million deal that values the company at $1.7 billion. Meanwhile, Suzhou Ascentage Pharma filed to list in the US to... Via Talk Markets CHRS Stock Earnings: Coherus BioSciences Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 CHRS stock results show that Coherus BioSciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Why Coherus Biosciences Stock Tumbled on Thursday March 14, 2024 The company fell well short of expectations for its fourth quarter. Via The Motley Fool Recap: Coherus BioSciences Q4 Earnings March 13, 2024 Via Benzinga Earnings Preview For Coherus BioSciences March 12, 2024 Via Benzinga Earnings Scheduled For March 13, 2024 March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. Via Benzinga Why Coherus BioSciences Stock Jumped Today February 06, 2024 As promised, Coherus is using the proceeds of a recent divestiture to pay down debt and reduce interest expenses. Via The Motley Fool Why Coherus BioSciences Stock Is Sinking Today January 23, 2024 The positive reaction to Coherus' sale of its ophthalmology franchise to Sandoz didn't last long. Via The Motley Fool Why Coherus Biosciences Popped Today January 22, 2024 Coherus is divesting its non-core ophthalmology franchise. Via The Motley Fool Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 22, 2024 Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the... Via Benzinga Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today? January 22, 2024 Coherus BioSciences agreed to sell its ophthalmology franchise for $170M to Sandoz. This aligns with CHRS' focus on oncology and will help reduce debt and overhead costs. Via Benzinga Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? January 22, 2024 Cartesian Therapeutics stock is falling on Monday as investors react to a delisting notice for RNAC shares due to its low trading price. Via InvestorPlace Why Is B. Riley Financial (RILY) Stock Down 11% Today? January 22, 2024 B. Riley Financial stock is falling on Monday as RILY investors react to reports of an SEC probe and the company's stance on the news. Via InvestorPlace Topics Regulatory Compliance Exposures Legal Regulatory Why Is Coherus BioSciences (CHRS) Stock Up 17% Today? January 22, 2024 Coherus BioSciences stock is rising on Monday as CHRS investors react to a $170 million divestment of its CIMERLI ophthalmology franchise. Via InvestorPlace Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket January 22, 2024 Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 22, 2024 We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday! Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session January 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 18, 2024 Via Benzinga Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday January 10, 2024 U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session. Via Benzinga Topics Stocks Exposures US Equities Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet December 29, 2023 Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. Via Benzinga FLJ Group, Bit Digital And Other Big Stocks Moving Higher In Friday's Pre-Market Session December 29, 2023 U.S. stock futures were slightly higher this morning, with the Dow Jones futures gaining around 15 points on Thursday. Shares of FLJ Group Limited(NASDAQ: FLJ) rose sharply in pre-market trading. Via Benzinga Topics Stocks Exposures US Equities Why Coherus BioSciences Stock Jumped Today December 28, 2023 Coherus finally received FDA approval for its Udenyca OnBody injector system. Via The Motley Fool Exposures Product Safety Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher December 27, 2023 U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 27, 2023 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 27, 2023 Via Benzinga Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December December 27, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Coherus BioSciences Stock Is Climbing Today December 27, 2023 Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Wednesday after the company announced the FDA approval of its pegfilgrastim delivery device, Udenyca Onbody. Via Benzinga Exposures Product Safety US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY December 27, 2023 U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while... Via Benzinga Topics Stocks Exposures Product Safety US Equities Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket December 27, 2023 Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.